EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,455 | -5.2% | 443 | 0.0% | 0.00% | – |
| Q2 2023 | $3,645 | +13.5% | 443 | 0.0% | 0.00% | – |
| Q1 2023 | $3,211 | -18.3% | 443 | 0.0% | 0.00% | – |
| Q4 2022 | $3,929 | -21.4% | 443 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 443 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -37.5% | 443 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -11.1% | 443 | +29.2% | 0.00% | – |
| Q4 2021 | $9,000 | 0.0% | 343 | +41.2% | 0.00% | – |
| Q3 2021 | $9,000 | -18.2% | 243 | +21.5% | 0.00% | – |
| Q2 2021 | $11,000 | +37.5% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -42.9% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +180.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -82.4% | 200 | -60.0% | 0.00% | – |
| Q1 2016 | $17,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |